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Abstract
Background: Clostridium difficile and methicillin-resistant Staphylococcus aureus are critical human pathogens and
of increasing concern in food animals. Because of the apparent impact of age on prevalence of these organisms,
studies of slaughter age pigs are important when considering the potential for contamination of food. This study
evaluated C. difficile and MRSA shedding by slaughter age pigs from farms across Canada.
Results: Clostridium difficile was isolated from 30/436 (6.9%) samples from 15/45 (33%) farms. After adjusting for
clustering at the herd level, the prevalence was 3.4%. Ribotype 078 (toxinotype V, North American Pulsotype 7) was
the most common strain, accounting for 67% of isolates. MRSA was isolated from 21/460 (4.6%) pigs from 5/46
(11%) farms. The prevalence in pigs after adjusting for clustering at the herd level was 0.2%. Seven different spa
types were identified, with 3 related spa types (t011, t034, new) accounting for 16 (76%) consistent with ST398
predominating.
Both MRSA and C. difficile samples were collected from 45 farms. Both MRSA and C. difficile were detected on 2
(4.4%), with C. difficile only on 13 (29%), MRSA only on 3 (6.7%) and neither on 27 (60%).
Conclusions: The prevalence of C. difficile and MRSA in slaughter age pigs was relatively low, particularly in
comparison with studies involving younger pigs. The predominance of C. difficile ribotype 078 and MRSA ST398
was not surprising, but there was diversity in strain types and the majority of isolates of both organisms were
strains that can be found in humans. While the prevalence of C. difficile and MRSA in slaughter age pigs was
relatively low, there is clearly potential for contamination of meat from healthy pigs carrying this pathogen into
slaughterhouses.
Background
Clostridium difficile and methicillin-resistant Staphylo-
coccus aureus are important causes of disease in humans
and of increasing concern in food animals. In pigs, C.
difficile infection (CDI) can cause severe enteritis in
young (1-7d old) piglets, often with high mortality [1-3].
Human CDI appears to be increasing in incidence and
severity internationally [4-6]. Additionally, while once
considered mainly a hospital-associated pathogen, com-
munity-associated CDI (CA-CDI) appears to be increas-
ing [7,8] and toxinotype V strains, particularly ribotype
078, appear to be over-represented in CA-CDI [9,10].
These strains have predominated in studies of pigs and
cattle [11-16] and have been found in retail meat
[17,18], raising concerns that C. difficile might be a zoo-
notic and foodborne infection [13,19,20]. Highly variable
(0-52%) shedding rates have been reported in studies of
healthy pigs [12,15,16,21,22]. However, studies reporting
high prevalences have involved young piglets and there
is evidence of a significant impact of age on C. difficile
shedding [15,23]. Evaluation of food contamination risks
requires an understanding of the prevalence of C. diffi-
cile shedding and the C. difficile types shed by slaugh-
ter-age pigs, not piglets.
Similarly, methicillin-resistant Staphylococcus aureus
(MRSA) was once predominantly a hospital-associated
pathogen in humans, but has emerged as an important
community-associated pathogen internationally.
Recently, livestock-associated MRSA (LA-MRSA),
* Correspondence: jsweese@uoguelph.ca
1Dept of Pathobiology, University of Guelph, Guelph, Ontario, Canada
Full list of author information is available at the end of the article
Weese et al. BMC Veterinary Research 2011, 7:41
http://www.biomedcentral.com/1746-6148/7/41
© 2011 Weese et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
caused by sequence type 398 (ST398) strains [24-26],
has emerged as an important public health issue, parti-
cularly in Europe. MRSA colonization has been identi-
fied in healthy pigs from various countries, sometimes
at high rates [25-30]. Similarly, high MRSA colonization
rates have been reported in pig farmers [29,31,32], and
associations between pig contact and both MRSA infec-
tion and MRSA colonization in humans have been
reported [33-38]. MRSA has also been identified in retail
meat [39-41], heightening concerns but currently with
unclear public health significance.
Prevalence studies have been reported for different pig
populations in different regions, with prevalence ranging
from 1 to 80% [25,28,30,42,43]. As with C. difficile,
there is evidence of age-related changes in MRSA colo-
nization rates [44] and study of pigs at the age of
slaughter is most relevant for assessment of food con-
tamination issues. Studies involving commingled pigs,
pigs at slaughterhouses or from multiple farms from the
same production systems have been performed [28,30],
but could introduce effects of clustering or transient
contamination from transportation and may therefore
not provide an optimal estimate of true population pre-
valence. For these reasons, studies of non-commingled
pigs close to the age of slaughter from a large number
of unassociated farms are required to obtain a better
estimate of the prevalence of MRSA colonization in pigs
that are ready to enter the food chain.
The objectives of this study were to determine the
prevalence of C. difficile and MRSA shedding by slaugh-
ter-age pigs on farms across Canada and to characterize
recovered isolates.
Methods
Study Population and Sample Collection
Commercial swine farms from across Canada were
recruited in conjunction with the Canadian Integrated
Program for Antimicrobial Resistance Surveillance
(CIPARS). This program has a network of farms and
veterinarians across Canada that participate in ongoing
surveillance and periodic research studies. Veterinarians
participating in CIPARS were contacted and asked to
recruit herds. On each participating farm, freshly passed
fecal samples were collected from pens containing
grower-finisher pigs close to the time of slaughter. A
single sample was collected per pen, to represent an
individual pig sample. The target was 10 pens per farm,
however on some farms, 10 separate pens were not
available so a smaller number of samples was obtained.
Additionally, nasal swabs were collected from 10 non-
comingled grower-finisher pigs that were close to
slaughter age. Fecal and nasal samples were not necessa-
rily collected from the same pigs, so C. difficile and
MRSA were analysed independently.
Clostridium difficile isolation
Approximately 1 g of feces was inoculated into 9 ml of
C. difficile agar base (Oxoid Company, Nepean, Canada)
with C. difficile moxalactam norfloxacin supplement
(Oxoid Company, Nepean, Canada)(CDMN) and 0.1%
sodium taurocholate and incubated anaerobically at 37°
C for 7 days. An aliquot of the broth was alcohol
shocked with an equal volume of anhydrous ethanol for
1 hour. This mixture was then centrifuged for 10 min at
4000 rpm. The supernatant was discarded and the pellet
was streaked onto a CDMN agar plate and incubated
anaerobically at 37°C for 48 h. Suspicious colonies were
subcultured onto blood agar and confirmed as C. diffi-
cile by Gram stain appearance, colony morphology,
characteristic odor and production of l-proline
aminopeptidase.
Clostridium difficile isolate characterization
Isolates were typed by PCR ribotyping as has been
described elsewhere [45]. In situations where the ribo-
type was known to be a recognized international ribo-
type through previous typing of reference strains from
the PHLS Anaerobic Reference Unit (Cardiff, UK), the
appropriate numerical designation (i.e. 078) was used.
Otherwise, internal nomenclature was used. Genes
encoding production of toxins A (tcdA) and B (tcdB)
were evaluated using PCR [46,47]. Detection of CDT
(binary toxin) was performed using PCR directed at
cdtB, the binding component [48]. Toxinotyping [49]
and pulsed field gel electrophoresis (PFGE) [50] were
performed on a representative of each toxigenic ribo-
type. Sequence analysis of tcdC was performed and
interpreted as previously described [51].
MRSA Isolation
Nasal swabs were inoculated into 9 ml of enrichment
broth consisting of 10 g tryptone/L, 75 g sodium chlor-
ide/L, 10 g mannitol/L and 2.5 g of yeast extract/L.
After 24 h incubation at 35°C, 50 ul of broth was inocu-
lated onto MRSA Chromogenic agar (BBL CHROMagar
MRSA, Becton, Dickinson and Company, Sparks, MD).
Plates were incubated at 35°C and read after 24 and 48
h. Isolates were identified as S. aureus by colony mor-
phology, Gram stain appearance, catalase reaction, coa-
gulase reaction and S. aureus latex agglutination test
(Pastorex Staph-plus, Bio-Rad, France). Methicillin-resis-
tance was confirmed by penicillin binding protein 2a
latex agglutination test (MRSA latex agglutination test,
Oxoid Ltd., Hants, UK).
MRSA Isolate Characterization
Isolates were typed by sequencing of the x region of the
protein A gene (spa typing) [52] and classified using the
Ridom system (http://www.spaserver.ridom.de). Real
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time PCR was used to detect the lukF and lukS compo-
nents of the Panton-Valentine leukocidin (PVL) [53].
Positive and negative controls were performed with each
PCR run.
Statistical Analysis
The crude prevalence was calculated for both C. difficile
and MRSA. The prevalence was then adjusted for clus-
tering at the herd level using Generalized Linear and
Latent Mixed Models (GLAMM) with adaptive quadra-
ture (Stata Intercooled version 10.1, Stata Corporation,
College Station, Texas, USA). Chi-squared test was used
to compare the herd level prevalence between provinces.
A P value of < 0.05 was considered significant.




Clostridium difficile was isolated from 30/436 (6.9%)
samples from 15/45 (33%) farms (Table 1). The preva-
lence after adjustment for clustering at the herd level
was 3.4%. Five to 10 samples were collected per farm
(median 10). There was a significant difference between
provinces at the farm level (P = 0.002), with the farm
prevalence ranging from 0-100%. On positive farms,
between 1 and 5 samples (median = 1), representing
between 10-100% of samples, were positive.
Seven different ribotypes were identified (Table 2).
Ribotype 078 isolates were classified as North American
Pulsotype (NAP) 7 by PFGE. One additional toxinotype
V ribotype was indistinguishable from NAP7 on PFGE,
however the other toxinotype V ribotype (S6) had a
PFGE pattern that is not consistent with any NAP type
and had a 5 band difference from NAP7. Three of the 6
toxigenic ribotypes 3 (50%), accounting for 82% of iso-
lates, have been previously identified in humans in
Canada [54].
On 7/15 (47%) positive farms, C. difficile was recov-
ered from more than one pig. On 3 of these, all isolates
were the same; ribotype 078. On 2 farms, there was a
combination of ribotype 078 and a single nontoxigenic
isolate. On 2 other farms, ribotype 078 plus 1 or 2 other
toxinotype V ribotypes were found. No disease attribu-
ted to C. difficile was reported on any of the participat-
ing farms.
MRSA
MRSA was isolated from 21/460 (4.6%) pigs from 5/46
(11%) farms (Table 3). The prevalence in pigs after
adjusting for clustering at the herd level was 0.2%. The
on-farm prevalence ranged from 0-70%, with a range of
20-70% for positive farms. There was not a statistically
significant difference in farm prevalence between pro-
vinces (P = 0.35)
Seven different spa types were identified, correspond-
ing to three different clones (Table 4). All isolates were
PVL negative. Three related spa types (t011, t034,
04652), accounting for 16 (76%) isolates were consistent
with ST398. Three spa types, t002 (n = 2), t5518 (n = 1)
and t067 (n = 1) were consistent with Canadian epi-
demic MRSA-2 (CMRSA-2). One additional spa type
(t064) was unrelated to the others and was consistent
with CMRSA-5.
A single spa type was found on two farms, one with 7
t034 isolates and one with a single t002 isolate. On the
3 other farms, two or 3 different spa types were
identified.
Combined
Both MRSA and C. difficile samples were collected from
45 farms. Both MRSA and C. difficile were detected on
2 (4.4%), with C. difficile only on 13 (29%), MRSA only
on 3 (6.7%) and neither on 27 (60%).
Discussion
This study has identified a relatively low prevalence of
both C. difficile and MRSA in pigs shortly before the
time of slaughter. These data are consistent with recent
studies demonstrating a significant impact of age on C.
difficile colonization in pigs [15,22,23,55], such a a longi-
tudinal study that reported a 96% cumulative prevalence
in young piglets, with colonization of 74% of piglets on
day 2 of life but only 3.7% in the same piglets on day 62
[23], and a similar study in an integrated swine opera-
tion reported C. difficile shedding in 50% of suckling
Table 1 Prevalence of Clostridium difficile shedding by slaughter age pigs in 5 difference Canadian provinces.
Province Number of pigs Unadjusted prevalence (%) (95% CI) Adjusted pig prevalence (%), (95% CI) Farm prevalence
A 100 4.0 (1.5-10.2) 3.0 (0.5-15.9) 3/11 (27%)
B 50 26 (15.7-39.8) 26 (15.7-39.8) 5/5 (100%)
C 100 4.0 (1.5-10.2) 4.0 (1.5-10.2) 4/10 (40%)
D 106 0 0 0/11
E 80 11.3 (6.0-20.2) 3.0 (0.2-31.4) 3/8 (38%)
Total 436 6.9 (4.9-9.7) 3.4 (0.8-13.6) 15/45 (33%)
Weese et al. BMC Veterinary Research 2011, 7:41
http://www.biomedcentral.com/1746-6148/7/41
Page 3 of 7
piglets, but only 3.9% of grower-finisher pigs and breed-
ing animals [15]. The reason for variation in prevalence
with age has not been specifically evaluated but may
relate to the poorly developed intestinal microflora in
young pigs, with more competition from other microor-
ganisms as the pig ages.
The relatively low farm- and pig-prevalence of MRSA
was somewhat surprising, although some of the adjusted
prevalence estimates had wide confidence intervals.
These data are in contrast to a previous Canadian study
that reported MRSA from 25% of pigs (piglets, weaners,
grower-finishers) and 45% of farms in Ontario,
Canada [29], as well as some studies from other regions
reporting colonization rates of 39-80% [25,28,30]. How-
ever, results are similar to the report of isolation of
MRSA from 1.3% of pigs in Switzerland at the time of
slaughter [42], as well as 0.8% in weaned pigs in Malay-
sia [56]. As with C. difficile, there appears to be a signif-
icant impact of age on MRSA colonization in pigs, with
MRSA colonization rates decreasing dramatically as pigs
age [44], and this may account for the low prevalence
reported here, perhaps because of changes in the nasal
commensal microflora or immune response.
The inter-provincial difference in prevalence in C. dif-
ficile was unexpected. There were no readily apparent
explanations, however specific farm management factors
were not queried because of the relatively small farm
sample size. Identification of factors that may influence
differences in C. difficile between farms or between
regions is important, in order to identify potential inter-
ventions for the reduction of C. difficile shedding.
Regardless of the reasons, the relatively low prevalence
of C. difficile and MRSA in pigs approaching the time of
slaughter may have implications for assessment of food-
borne contamination. While the prevalence in young
piglets may have pig-health implications (at least for C.
difficile), the relevance for foodborne contamination is
limited because young piglets are rarely slaughtered for
food. The prevalence of C. difficile or MRSA in pigs at
or shortly before the time of slaughter is presumably
more relevant, and this study indicates a relatively low
prevalence. Additionally, the potential for marked varia-
tion in prevalence simply as a factor of age must be
considered in studies involving C. difficile and MRSA in
pigs and likely other animal species.
Despite the relatively low prevalence, the potential for
food as a source of C. difficile and MRSA for humans
cannot be dismissed. Contamination of retail meat
clearly can occur [17,39-41,57-59], but limited informa-
tion is available regarding the origins of food contami-
nation. Prospective studies of the slaughter and
processing systems are required to determine the source,
or sources, of contamination and identify potential
interventions.
Clostridium difficile typing data were not particularly
surprising. Ribotype 078, a toxinotype V strain, predo-
minated, as has been previously reported in studies of
pigs [12-14,21], but there were two other toxinotype V
Table 2 Clostridium difficile isolated from healthy slaughter age pigs in Canada.
Ribotype n (%) TT PFGE Toxin genes tcdC Farms Provinces
078 20 (67%) V NAP7 tcdA, tcdB, cdtB 39 bp deletion, C184T mutation 12 A, B, C, E
S6 3 (10%) V NAP7-like tcdA, tcdB, cdtB 39 bp deletion, C184T mutation 2 E
MOH-S 2 (6.7%) 0 Non-epidemic clone tcdA, tcdB Wild-type 1 A
R 1 (3.3%) 0 Non-epidemic clone tcdA, tcdB Wild-type 1 C
S7 1 (3.3%) V NAP7 tcdA, tcdB, cdtB 39 bp deletion, C184T mutation 1 E
OVCAA 1 (3.3%) 0 Non-epidemic clone tcdA, tcdB 18 bp deletion 1 A




Table 3 Isolation of methicillin-resistant Staphylococcus aureus (MRSA) from slaughter-age pigs in Canada.
Province Number of farms, pigs Unadjusted pig prevalence (%, 95% CI) Adjusted pig prevalence (%, 95% CI) Farm prevalence
A 10, 100 0 0 0
B 5, 50 0 0 0
C 10,100 11 (6.2-18.8) 0.04 (0.0-99.8) 30% (3/10)
D 13, 130 0.8 (0.1-5.3) 0.77 (0.1-5.3) 7.7% (1/13)
E 8, 80 11.3 (6.0-20.2) 0.35 (0-88.8) 25% (2/8)
Total 46, 460 4.6 (3.0-6.9) 0.002 (0-12.8) 13% (6/46)
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ribotypes. Non-ribotype 078 toxinotype V strains have
been reported previously in pigs, particularly ribotype
066 [12,16,21]. Ribotype 066 was not identified in this
study and the lack of a standard international system for
identifying and naming uncommon ribotypes hampers
comparison of uncommon isolates from different stu-
dies. It is, therefore, unclear whether the two non-ribo-
type 078/066 ribotypes identified here have been
reported in pigs elsewhere. It is likely that these two
strains are closely related to, and probably evolved from,
ribotype 078. Alterations in tcdC, a gene that down reg-
ulates production of toxins A and B has been linked to
hypervirulence in some C. difficile strains, particularly
ribotypes 027 and 078 [10,60], although the true role of
this gene in virulence is still unclear. Ribotype 078, S6
and S7 possessed the expected 39 bp deletion and
C184T nonsense mutation, providing further support to
the suspicion that they are closely related.
Similarly, the predominance of spa types that corre-
spond to ST398 was not unexpected, given the predomi-
nance of this clone in pigs in most regions [25,28,30,61].
However, while ST398 has accounted for virtually all
isolates reported in pigs from many regions, other
strains have been previously identified in pigs [27,29]. In
this study, two human epidemic clones were identified.
The first, CMRSA-2 (also known as USA100) is an ST5
strain that is the most common cause of hospital-asso-
ciated MRSA infection in humans in Canada [62], as
well as the most common strain found in colonized
humans in the US [63]. It accounted for 14% of isolates
in an earlier study of pigs in Ontario [29] and 15% in
this study, but has not, to our knowledge, been reported
in pigs elsewhere. Interestingly, this strain accounted for
29% and 100% of MRSA isolates recovered from pork in
two recent studies of retail meat in Canada [40,41]. The
other strain was spa type t064 that corresponds to
CMRSA-5 (USA500), an ST8 strain that is a relatively
uncommon human epidemic clone [63], but commonly
reported in horses in some regions [29]. This strain has
not, to our knowledge, been previously isolated from
pigs, however it accounted for 38% of MRSA isolates in
a study of Canadian retail pork [41]. The presence of
both livestock-associated and human epidemic clones
suggests that there may be multiple routes of MRSA
exposure in pigs, both from other pigs and from
humans. ST398 MRSA can reasonably be assumed to
have originated in livestock, although humans can carry
this strain and could presumably pass it between pigs.
The human epidemic clones found in pigs almost cer-
tainly were ultimately from humans, since parallel devel-
opment of these strains in pigs is extremely unlikely.
However, it is clear that both livestock associated and
human MRSA clones can be transmitted within and
between pigs and humans.
No pigs enrolled in this study had signs of clinical
MRSA infection. While MRSA can cause disease in
pigs [64], clinical infections appear to be quite rare,
something that is positive from a pig health standpoint
but which allows MRSA to be present undetected on
farms.
Interestingly, the presence of both MRSA and C. diffi-
cile on a farm was uncommon, being identified in only
4.4% of farms. The reasons for this are unclear but since
MRSA and C. difficile share various risk factors in
humans (e.g. antimicrobial administration), it is some-
what surprising that there was no apparent association
between the presence or absence of these two pathogens
on farms.
Conclusions
Both C. difficile and MRSA were identified in a small
percentage of pigs at the age of slaughter, consisting
mainly of strains that are of concern for human health.
The public health risk posed by C. difficile and MRSA
in Canadian pigs is unclear, partly because of poor
understanding of the role of livestock associated MRSA
and C. difficile strains in community-associated disease
in people in the country. ST398 MRSA infections in
humans appear to be rare in Canada, although cases
have been recently identified and there is concern that
Table 4 Typing data for methicillin-resistant Staphylococcus aureus (MRSA) isolated from slaughter-age pigs in Canada.
Spa type n Repeat pattern Farms Province
t011 8 (38%) 08-16-02-25————————————34-24-25 5, 9 C
t034 7 (33%) 08-16-02-25-02-25———34-24-25 28 E
t4652 1 (4.8%) 08-16-02-25-02-25—————— 24-25 9 C
t002 2 (9.5%) 26-23-17-34-17————20-17-12-17-16 13, 24 D, E
t5518 1 (4.8%) 26-23-17-34-17-23————17-12-17-16 5 E
t067 1 (4.8%) 26-23-17-34-17————20-17-12-17 5 E
t064 1 (4.8%) 11-19-12-05-17-34-24-34-22-25 13 E
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they could increase [65]. The presence of these two
pathogens in pigs, albeit at relatively low prevalence,
does not necessarily indicate a human health risk, either
from direct contact or foodborne contamination, how-
ever it should not be dismissed. A better understanding
of the epidemiology of C. difficile and MRSA in live-
stock and humans is required to help elucidate the role
of animals in human infections and to identify possible
interventions to reduce the potential public health
impact of this important pathogen.
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